Scientists
Scientists in Japan have made a breakthrough discovery in the fight against ovarian clear cell carcinoma, a type of cancer that is notorious for its aggressive behavior and poor prognosis. Recent studies have shown that overexpression of osteopontin (OPN) is a hallmark of this disease, and researchers have now revealed
Scientists
In a groundbreaking study from Kumamoto, Japan, researchers investigated the role of tumor-associated macrophages (TAMs) in intrahepatic cholangiocarcinoma (ICC), a type of liver cancer. The study found that CD163-positive macrophages, a marker of M2 macrophages, were positively correlated with angiogenesis, immunosuppression, and poor clinical prognosis in ICC patients. Notably, patients
Cancer research
A recent study published in Brain Pathology has found that the leptin and leptin receptor system is overexpressed in brain tumors and correlates with the degree of malignancy. Researchers used immunohistochemistry to screen 87 human brain tumor biopsies and detected leptin and its receptor in 55.2% and 60.9%
Cancer research
Scientists from the University of Mississippi have reported the potential of pseudolaric acid B (PAB) in treating leukemia, as it selectively inhibits the growth of human leukemia cells while sparing normal blood cells. The study, published in the Journal of Cancer Research and Clinical Oncology, investigated the effects of PAB
Cancer research
Scientists from the University of Copenhagen have made groundbreaking discoveries in cancer gene therapy. The study, titled "Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions," has shed light on the potential of peptide nucleic acid (PNA) conjugates to modulate pre-mRNA splicing of
Cancer research
Researchers in Kanazawa, Japan, have conducted a study to investigate the biodistribution of bevacizumab in peritoneal metastatic models of gastric cancer. The aim of the study was to clarify which method of therapy, systemic or regional, is more effective in treating peritoneal metastasis. A highly peritoneal-seeding cell line of gastric
Cancer research
Researchers in the United States have made significant advancements in cancer gene therapy by developing multifunctional nanoparticles that can deliver small interfering RNA and doxorubicin, overcoming drug resistance in cancer. This breakthrough study, published in the Journal of Biological Chemistry, showcases two nanoparticle formulations, LPD and LPD-II, designed to co-deliver
Cancer research
A groundbreaking study published in Clinical Breast Cancer has revealed a wealth of information on the potential of antiangiogenic therapies in treating early-stage breast cancer. Researchers from Vanderbilt University have conducted a comprehensive review of existing studies, clinical trials, and research databases, highlighting the promising results of antiangiogenic agents in
Cancer research
Active immunotherapy is emerging as a potential therapeutic approach for prostate cancer, and new data suggests that a novel vaccine could be a game-changer in the fight against this deadly disease. Researchers in Athens, Greece, have conducted the first phase I trial of an Ii-Key/HER-2/neu(776-790) hybrid peptide
Cancer research
Researchers at the Mayo Clinic's College of Medicine have made significant discoveries regarding the treatment of cholangiocarcinoma, a type of liver cancer. According to a study published in Hepatology, sorafenib, a multikinase inhibitor, has been found to inhibit the JAK/STAT signaling pathway in cholangiocarcinoma cells, leading to
Cancer research
Researchers have uncovered a new mechanism of modulating p53 transcriptional activity, which is responsive to low concentrations of nitric oxide (NO) and independent of DNA damage signaling. The study highlights the importance of nitration at tyrosine 327 in p53 activation, promoting p53 oligomerization and activation. This discovery may have significant
Cancer
Researchers from Kyoto University, Japan, have made a groundbreaking discovery in the fight against metastatic lung cancer. By combining all-trans-retinoic acid (ATRA) with cationic liposome/interleukin 12 (IL-12) plasmid DNA (pDNA) complexes, they were able to enhance growth inhibition of metastatic lung tumors in mice. This innovative treatment approach showed
